查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1508488

性傳染病 (STD) 診斷市場 [診斷測試類型：分子測試、血清學測試、照護端測試和其他（免疫學測試等）] - 全球行業分析、規模、佔有率、成長、趨勢和預測，2024-2034

Sexually Transmitted Diseases (STD) Diagnostics Market [Type of Diagnostic Test: Molecular Test, Serologic Test, Point of Care Test, and Others (Immunological Test etc.)] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 157 Pages | 商品交期: 2-10個工作天內

價格

性傳染病 (STD) 診斷市場 - 報告範圍

TMR 關於全球性傳染病 (STD) 診斷市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。傳播疾病（STD）診斷市場，以2024年為基準年，2034年為預測年。該報告也提供了2024年至2034年全球性傳染病（STD）診斷市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解性傳染病 (STD) 診斷市場。

市場概況
2023年市場價值 71 億美元
2034 年市場價值 159 億美元
複合年成長率 7.6%

該報告深入探討了全球性傳染病（STD）診斷市場的競爭格局。全球性傳染病 (STD) 診斷市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球性傳染病 (STD) 診斷市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034 年全球市場分析與預測

第 5 章：關鍵見解

  • 主要產品和品牌分析
  • 波特五力分析
  • CDC 2022 年性傳染病 (STI) 監測
  • 關於低收入和中等收入國家性傳染感染的見解

第 6 章：全球市場分析與預測：依診斷測試類型

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年診斷測試類型市場價值預測
    • 分子測試
    • 血清學檢測
    • 照護端測試
    • 其他（免疫學檢測等）
  • 按診斷測試類型分類的市場吸引力

第 7 章：全球市場分析與預測：按疾病類型

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按疾病類型分類的市場價值預測
    • 衣原體
    • 淋病
    • 梅毒
    • HIV愛滋病
    • 人類乳突病毒 (HPV)
    • 生殖器皰疹
    • 其他性病
  • 按疾病類型分類的市場吸引力

第 8 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年最終用戶市場價值預測
    • 醫院和診所
    • 診斷實驗室
    • 其他（研究機構、家庭護理機構等）
  • 最終用戶的市場吸引力

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 10 章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 12 章：亞太市場分析與預測

  • 中國
  • 印度
  • 日本
  • 澳洲和紐西蘭
  • 亞太地區其他地區

第 13 章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司市佔率分析 (2023)
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Hologic Inc.
    • Creative Diagnostics
    • Abbott Laboratories
    • Quest Diagnostics
    • BD
    • QIAGEN
    • Cepheid
    • bioMerieux
Product Code: TMRGL1207

Sexually Transmitted Diseases (STD) Diagnostics Market - Scope of Report

TMR's report on the global sexually transmitted diseases (STD) diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global sexually transmitted diseases (STD) diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global sexually transmitted diseases (STD) diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the sexually transmitted diseases (STD) diagnostics market.

Market Snapshot
Market Value in 2023US$ 7.1 Bn
Market Value in 2034US$ 15.9 Bn
CAGR7.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global sexually transmitted diseases (STD) diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global sexually transmitted diseases (STD) diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global sexually transmitted diseases (STD) diagnostics market.

The report delves into the competitive landscape of the global sexually transmitted diseases (STD) diagnostics market. Key players operating in the global sexually transmitted diseases (STD) diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global sexually transmitted diseases (STD) diagnostics market profiled in this report.

Key Questions Answered in Global sexually transmitted diseases (STD) diagnostics Market Report:

  • What is the sales/revenue generated by sexually transmitted diseases (STD) diagnostics across all regions during the forecast period?
  • What are the opportunities in the global sexually transmitted diseases (STD) diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Sexually Transmitted Diseases (STD) Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global sexually transmitted diseases (STD) diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global sexually transmitted diseases (STD) diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global sexually transmitted diseases (STD) diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sexually Transmitted Diseases (STD) Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, 2020-2034

5. Key Insights

  • 5.1. Key Product & Brand Analysis
  • 5.2. Porter's Five Forces Analysis
  • 5.3. CDC's 2022 Sexually Transmitted Disease (STI) Surveillance
  • 5.4. Insights on Sexually Transmitted Infections in Low and Middle Income Countries

6. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, By Type of Diagnostic Test

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 6.3.1. Molecular Test
    • 6.3.2. Serologic Test
    • 6.3.3. Point of Care Test
    • 6.3.4. Others (Immunological Test etc.)
  • 6.4. Market Attractiveness By Type of Diagnostic Test

7. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, By Disease Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Disease Type, 2020-2034
    • 7.3.1. Chlamydia
    • 7.3.2. Gonorrhea
    • 7.3.3. Syphilis
    • 7.3.4. HIV/AIDS
    • 7.3.5. Human Papillomavirus (HPV)
    • 7.3.6. Genital Herpes
    • 7.3.7. Others STDs
  • 7.4. Market Attractiveness By Disease Type

8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Others (Research Institutes, Homecare Settings etc.)
  • 8.4. Market Attractiveness By End-user

9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 10.2.1. Molecular Test
    • 10.2.2. Serologic Test
    • 10.2.3. Point of Care Test
    • 10.2.4. Others (Immunological Test etc.)
  • 10.3. Market Value Forecast By Disease Type, 2020-2034
    • 10.3.1. Chlamydia
    • 10.3.2. Gonorrhea
    • 10.3.3. Syphilis
    • 10.3.4. HIV/AIDS
    • 10.3.5. Human Papillomavirus (HPV)
    • 10.3.6. Genital Herpes
    • 10.3.7. Others STDs
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type of Diagnostic Test
    • 10.6.2. By Disease Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 11.2.1. Molecular Test
    • 11.2.2. Serologic Test
    • 11.2.3. Point of Care Test
    • 11.2.4. Others (Immunological Test etc.)
  • 11.3. Market Value Forecast By Disease Type, 2020-2034
    • 11.3.1. Chlamydia
    • 11.3.2. Gonorrhea
    • 11.3.3. Syphilis
    • 11.3.4. HIV/AIDS
    • 11.3.5. Human Papillomavirus (HPV)
    • 11.3.6. Genital Herpes
    • 11.3.7. Others STDs
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospitals & Clinics
    • 11.4.2. Diagnostic Laboratories
    • 11.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 11.5. Market Value Forecast By Country, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type of Diagnostic Test
    • 11.6.2. By Disease Type
    • 11.6.3. By End-user
    • 11.6.4. By Country

12. Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 12.2.1. Molecular Test
    • 12.2.2. Serologic Test
    • 12.2.3. Point of Care Test
    • 12.2.4. Others (Immunological Test etc.)
  • 12.3. Market Value Forecast By Disease Type, 2020-2034
    • 12.3.1. Chlamydia
    • 12.3.2. Gonorrhea
    • 12.3.3. Syphilis
    • 12.3.4. HIV/AIDS
    • 12.3.5. Human Papillomavirus (HPV)
    • 12.3.6. Genital Herpes
    • 12.3.7. Others STDs
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospitals & Clinics
    • 12.4.2. Diagnostic Laboratories
    • 12.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 12.5. Market Value Forecast By Country, 2020-2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type of Diagnostic Test
    • 12.6.2. By Disease Type
    • 12.6.3. By End-user
    • 12.6.4. By Country

13. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 13.2.1. Molecular Test
    • 13.2.2. Serologic Test
    • 13.2.3. Point of Care Test
    • 13.2.4. Others (Immunological Test etc.)
  • 13.3. Market Value Forecast By Disease Type, 2020-2034
    • 13.3.1. Chlamydia
    • 13.3.2. Gonorrhea
    • 13.3.3. Syphilis
    • 13.3.4. HIV/AIDS
    • 13.3.5. Human Papillomavirus (HPV)
    • 13.3.6. Genital Herpes
    • 13.3.7. Others STDs
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospitals & Clinics
    • 13.4.2. Diagnostic Laboratories
    • 13.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 13.5. Market Value Forecast By Country, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type of Diagnostic Test
    • 13.6.2. By Disease Type
    • 13.6.3. By End-user
    • 13.6.4. By Country

14. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type of Diagnostic Test, 2020-2034
    • 14.2.1. Molecular Test
    • 14.2.2. Serologic Test
    • 14.2.3. Point of Care Test
    • 14.2.4. Others (Immunological Test etc.)
  • 14.3. Market Value Forecast By Disease Type, 2020-2034
    • 14.3.1. Chlamydia
    • 14.3.2. Gonorrhea
    • 14.3.3. Syphilis
    • 14.3.4. HIV/AIDS
    • 14.3.5. Human Papillomavirus (HPV)
    • 14.3.6. Genital Herpes
    • 14.3.7. Others STDs
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospitals & Clinics
    • 14.4.2. Diagnostic Laboratories
    • 14.4.3. Others (Research Institutes, Homecare Settings etc.)
  • 14.5. Market Value Forecast By Country, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type of Diagnostic Test
    • 14.6.2. By Disease Type
    • 14.6.3. By End-user
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. F. Hoffmann-La Roche Ltd
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Thermo Fisher Scientific Inc.
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Hologic Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Creative Diagnostics
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Abbott Laboratories
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Quest Diagnostics
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. BD
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. QIAGEN
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Cepheid
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. bioMerieux
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 02: Global STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 03: Global STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 04: Global STD Diagnostics Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America STD Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 07: Europe STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 08: Latin America STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 09: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 10: North America STD Diagnostics Market Value (US$ Mn) Forecast, by Type of Diagnostic Test, 2020-2034
  • Table 11: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 12: Europe STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 13: Latin America STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 14: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 15: North America STD Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 17: Europe STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 18: Latin America STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 19: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 20: North America STD Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 21: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Europe STD Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 23: Latin America STD Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 24: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

List of Figures

  • Figure 01: Global STD Diagnostics Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global STD Diagnostics Market Value Share, by Type of Diagnostic Test, 2023
  • Figure 03: Global STD Diagnostics Market Value Share, by Disease Type, 2023
  • Figure 04: Global STD Diagnostics Market Value Share, by End-user, 2023
  • Figure 05: Global STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 06: Global STD Diagnostics Market Share Analysis, by Type of Diagnostic Test, 2022
  • Figure 07: Global STD Diagnostics Market Share Analysis, by Type of Diagnostic Test, 2031
  • Figure 08: Global STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 09: Global STD Diagnostics Market Value (US$ Mn), by Molecular Test, 2017-2031
  • Figure 10: Global STD Diagnostics Market Value Share Analysis, by Molecular Test, 2023 and 2034
  • Figure 11: Global STD Diagnostics Market Value (US$ Mn), by Serologic Test, 2017-2031
  • Figure 12: Global STD Diagnostics Market Value Share Analysis, by Serologic Test, 2023 and 2034
  • Figure 13: Global STD Diagnostics Market Value (US$ Mn), by Point of Care Test, 2017-2031
  • Figure 14: Global STD Diagnostics Market Value Share Analysis, by Point of Care Test, 2023 and 2034
  • Figure 15: Global STD Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 16: Global STD Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 17: Global STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 18: Global STD Diagnostics Market Share Analysis, by Disease Type, 2022
  • Figure 19: Global STD Diagnostics Market Share Analysis, by Disease Type, 2031
  • Figure 20: Global STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 21: Global STD Diagnostics Market Value (US$ Mn), by Clinical Disease Type, 2017-2031
  • Figure 22: Global STD Diagnostics Market Value Share Analysis, by Chlamydia, 2023 and 2034
  • Figure 23: Global STD Diagnostics Market Value (US$ Mn), by Gonorrhea, 2017-2031
  • Figure 24: Global STD Diagnostics Market Value Share Analysis, by Gonorrhea, 2023 and 2034
  • Figure 25: Global STD Diagnostics Market Value (US$ Mn), by Syphilis, 2017-2031
  • Figure 26: Global STD Diagnostics Market Value Share Analysis, by Syphilis, 2023 and 2034
  • Figure 27: Global STD Diagnostics Market Value (US$ Mn), by HIV/AIDS, 2017-2031
  • Figure 28: Global STD Diagnostics Market Value Share Analysis, by HIV/AIDS, 2023 and 2034
  • Figure 29: Global STD Diagnostics Market Value (US$ Mn), by Human Papillomavirus (HPV), 2017-2031
  • Figure 30: Global STD Diagnostics Market Value Share Analysis, by Human Papillomavirus (HPV), 2023 and 2034
  • Figure 31: Global STD Diagnostics Market Value (US$ Mn), by Genital Herpes, 2017-2031
  • Figure 32: Global STD Diagnostics Market Value Share Analysis, by Genital Herpes, 2023 and 2034
  • Figure 33: Global STD Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 34: Global STD Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 35: Global STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 36: Global STD Diagnostics Market Share Analysis, by End-user, 2022
  • Figure 37: Global STD Diagnostics Market Share Analysis, by End-user, 2031
  • Figure 38: Global STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 39: Global STD Diagnostics Market Value (US$ Mn), by Hospitals & Clinics, 2017-2031
  • Figure 40: Global STD Diagnostics Market Value Share Analysis, by Hospitals & Clinics, 2023 and 2034
  • Figure 41: Global STD Diagnostics Market Value (US$ Mn), by Diagnostic Laboratories, 2017-2031
  • Figure 42: Global STD Diagnostics Market Value Share Analysis, by Diagnostic Laboratories, 2023 and 2034
  • Figure 43: Global STD Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 44: Global STD Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 45: Global STD Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 46: Global STD Diagnostics Market Share Analysis, by Region, 2022
  • Figure 47: Global STD Diagnostics Market Share Analysis, by Region, 2031
  • Figure 48: Global STD Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 49: North America STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 50: North America STD Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 51: North America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 52: North America STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 53: North America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 54: North America STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 55: North America STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 56: North America STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 57: Europe STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 58: Europe STD Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 59: Europe STD Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 60: North America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 61: North America STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 62: Europe STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 63: Europe STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 64: Europe STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 65: Europe STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Asia Pacific STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,2020-2034
  • Figure 67: Asia Pacific STD Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Asia Pacific STD Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 69: Asia Pacific STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 70: Asia Pacific STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 71: Asia Pacific STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 72: Asia Pacific STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 73: Asia Pacific STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 74: Asia Pacific STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 75: Latin America STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 76: Latin America STD Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 77: Latin America STD Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 78: Latin America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 79: Latin America STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 80: Latin America STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 81: Latin America STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 82: Latin America STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 83: Latin America STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 84: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 85: Middle East & Africa STD Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 86: Middle East & Africa STD Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 87: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Share Analysis, by Type of Diagnostic Test, 2023 and 2034
  • Figure 88: Middle East & Africa STD Diagnostics Market Attractiveness Analysis, by Type of Diagnostic Test, 2024-2034
  • Figure 89: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 90: Middle East & Africa STD Diagnostics Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 91: Middle East & Africa STD Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 92: Middle East & Africa STD Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034